Gene · 1946
Papers1,982
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,982
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy. | Int J Mol Sci | 2023 | 37511569 | PubTator, text mining | PubMed |
| Regulation of mTOR Signaling: Emerging Role of Cyclic Nucleotide-Dependent Protein Kinases and Implications for Cardiometabolic Disease. | Int J Mol Sci | 2023 | 37511253 | PubTator, text mining | PubMed |
| Nuclear Receptor Subfamily 2 Group E Member 3 (NR2E3): Role in Retinal Development and Disease. | Genes (Basel) | 2023 | 37510230 | PubTator, text mining | PubMed |
| A Diagnostic Gene-Expression Signature in Fibroblasts of Amyotrophic Lateral Sclerosis. | Cells | 2023 | 37508548 | PubTator, text mining | PubMed |
| Refining the electroclinical spectrum of NPRL3-related epilepsy: A novel multiplex family and literature review. | Epilepsia Open | 2023 | 37491868 | PubTator, text mining | PubMed |
| Sanguisorba officinalis L. enhances the 5-fluorouracil sensitivity and overcomes chemoresistance in 5-fluorouracil-resistant colorectal cancer cells via Ras/MEK/ERK and PI3K/Akt pathways. | Heliyon | 2023 | 37484409 | PubTator, text mining | PubMed |
| Cryo-EM structure and polymorphic maturation of a viral transduction enhancing amyloid fibril. | Nat Commun | 2023 | 37464004 | PubTator, text mining | PubMed |
| Expression of mTOR in normal and pathological conditions. | Mol Cancer | 2023 | 37454139 | PubTator, text mining | PubMed |
| Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications. | Cancers (Basel) | 2023 | 37444544 | PubTator, text mining | PubMed |
| SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks. | Nat Methods | 2023 | 37443338 | PubTator, text mining | PubMed |
| The Eph/Ephrin system in primary bone tumor and bone cancer pain. | Aging (Albany NY) | 2023 | 37413995 | PubTator, text mining | PubMed |
| BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report. | Front Pharmacol | 2023 | 37397496 | PubTator, text mining | PubMed |
| Subcellular second messenger networks drive distinct repellent-induced axon behaviors. | Nat Commun | 2023 | 37369692 | PubTator, text mining | PubMed |
| A reaction network scheme for hidden Markov model parameter learning. | J R Soc Interface | 2023 | 37340782 | PubTator, text mining | PubMed |
| A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer. | BMC Med Genomics | 2023 | 37337170 | PubTator, text mining | PubMed |
| The influence of lifestyle changes (diet, exercise and stress reduction) on prostate cancer tumour biology and patient outcomes: A systematic review. | BJUI Compass | 2023 | 37334023 | PubTator, text mining | PubMed |
| Overexpression of LINC00607 inhibits cell growth and aggressiveness by regulating the miR-1289/EFNA5 axis in non-small-cell lung cancer. | Open Med (Wars) | 2023 | 37333453 | PubTator, text mining | PubMed |
| Non-typical persistent hyperplastic primary vitreous: a rare case report and review of the literature. | BMC Ophthalmol | 2023 | 37312173 | PubTator, text mining | PubMed |
| Two New Aluminoborates with 3D Porous-Layered Frameworks. | Molecules | 2023 | 37298862 | PubTator, text mining | PubMed |
| Mechanical and Electronic Properties of Al(111)/6H-SiC Interfaces: A DFT Study. | Molecules | 2023 | 37298818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1946/papers?page=8